Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Gastroenterology | Family Medicine | Infections and Infectious Diseases
Search Medical Condition
Irritable Bowel Syndrome (IBS) Clinical Trials
A listing of Irritable Bowel Syndrome (IBS) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (133) clinical trials
IBS-Diarrhea
If you've tried Imodium and are still experiencing symptoms of abdominal pain and diarrhea, learn how you could be eligible to participate in a research study of an approved drug for Irritable Bowel Syndrome with diarrhea (IBS-D).
Irritable Bowel Syndrome (IBS)
Seeking research volunteers for a clinical study of irritable bowel syndrome (IBS).
A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C (T3MPO-1)
During the 12-week treatment period, subjects will record daily assessments including: frequency and timing of bowel movements; sensation and complete bowel emptying; consistency of bowel movements; degree of straining, worst abdominal pain, abdominal discomfort, abdominal bloating, abdominal fullness and abdominal cramping. Subjects will also record weekly assessments including: adequate relief ...
Have you been diagnosed with IBS-C
Men or women 18-75 years of age Abdominal discomfort Constipation Up to $600 for time and travel
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.
Investigational Irritable Bowel Syndrome with Constipation (IBS-C) Study
HWC Women's Research Center is conducting a 12 week clinical research study of an investigational medication for IBS-C. You may qualify for: Investigational Medication Study-related labs and care Reimbursement for time and travel
Irritable Bowel Syndrome with Constipation (IBS-C)
SP304203-04 : Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IIBS-C).
Irritable Bowel Syndrome with Constipation (IBS-C) Research Study
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Irritable Bowel Syndrome with Constipation
Do you have uncomfortable bloating? Feeling gassy all the time? Having less than 3 bowel movements in a week? You might have irritable bowel syndrome. You may qualify to participate in a research study at Boston Clinical Trials with new investigational medication for irritable bowel syndrome with constipation. (IBS-C)
